Kaplan-Meier survival analysis of mice groups made of pooled MSC-Vcz treatments: 1) in one group we combined treatments with all tested 5-FIC concentrations (20, 50 and 100 mg/mouse), 2) the second group contained treatments with all tested 5-FU concentrations (20 and 50 mg/mouse) and 3) the third treatment group was composed of MSC-Vcz controls. The asterisk symbol (*) marks the statistical significance between MSC-Vcz + 5-FIC and control treatment groups, determined by the p-value = 0.01 of the Chi-square test. The Log rank value for 5-FIC vs control groups was determined as p < 0.001 (significant), whereas the Log rank value for 5-FU vs control groups was determined as p = 0.098 (not significant). (PDF 296 kb
Figure S7. Roflumilast potentiated the anti-tumor effect of IFN-α in vivo. T24 cells (5 × 106 cells/...
Table S1. Doubling time in hours of the investigated cell lines and fibroblasts B. Table S2. Real ti...
Figure S9. Potency of KRA-533 in genetically engineered LSL-KRASG12D LKB1fl/fl (KL) mice. (A) and (B...
Figure S1. Inhibition of PI3Kα/δ improves overall survival in CT-26 tumor and is active in low and h...
Chronic treatment with gefitinib and PWT-458, alone or in combination, does not cause eight loss in ...
Acute toxicity studies of DAT1. Swiss Albino mice were divided into 6 groups of 6 mice each and were...
Histology analysis of extra MFP tumor developed in later stage in a mouse treated with MEDI3039. (A)...
Figure 1 photographs of solid tumor (A), tumor weight and relative tumor volume of solid tumor (B) t...
First MEDI3039 experiment in MFP model. This experiment was performed prior to dose-response experim...
Figure S1. a Cancer-associated fibroblasts (CAFs) culture-conditioned media used with MKN-45 and MKN...
MEDI3039 inhibited tumor metastases and extended animal survival in MB231T lung metastasis model. Th...
Tumor growth curves (a) and body weight changes (b) of the same set of experimental groups as descri...
a Evaluation of the percentages of human CD45+ TILs present in MC1 PDX tumors engrafted in hNSG mice...
Multidrug-resistance phenotype of murine MDR1 gene-modified 32D cells. 32D cells transduced with LV....
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
Figure S7. Roflumilast potentiated the anti-tumor effect of IFN-α in vivo. T24 cells (5 × 106 cells/...
Table S1. Doubling time in hours of the investigated cell lines and fibroblasts B. Table S2. Real ti...
Figure S9. Potency of KRA-533 in genetically engineered LSL-KRASG12D LKB1fl/fl (KL) mice. (A) and (B...
Figure S1. Inhibition of PI3Kα/δ improves overall survival in CT-26 tumor and is active in low and h...
Chronic treatment with gefitinib and PWT-458, alone or in combination, does not cause eight loss in ...
Acute toxicity studies of DAT1. Swiss Albino mice were divided into 6 groups of 6 mice each and were...
Histology analysis of extra MFP tumor developed in later stage in a mouse treated with MEDI3039. (A)...
Figure 1 photographs of solid tumor (A), tumor weight and relative tumor volume of solid tumor (B) t...
First MEDI3039 experiment in MFP model. This experiment was performed prior to dose-response experim...
Figure S1. a Cancer-associated fibroblasts (CAFs) culture-conditioned media used with MKN-45 and MKN...
MEDI3039 inhibited tumor metastases and extended animal survival in MB231T lung metastasis model. Th...
Tumor growth curves (a) and body weight changes (b) of the same set of experimental groups as descri...
a Evaluation of the percentages of human CD45+ TILs present in MC1 PDX tumors engrafted in hNSG mice...
Multidrug-resistance phenotype of murine MDR1 gene-modified 32D cells. 32D cells transduced with LV....
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
Figure S7. Roflumilast potentiated the anti-tumor effect of IFN-α in vivo. T24 cells (5 × 106 cells/...
Table S1. Doubling time in hours of the investigated cell lines and fibroblasts B. Table S2. Real ti...
Figure S9. Potency of KRA-533 in genetically engineered LSL-KRASG12D LKB1fl/fl (KL) mice. (A) and (B...